98%
921
2 minutes
20
Purpose: is a proposed colorectal cancer (CRC) predisposition gene, with only four families with putative loss-of-function (pLoF) variants published. The prevalence, phenotypic spectrum, and clinical management recommendations for heterozygotes remain unknown.
Methods: Retrospective review of approximately 950,000 individuals undergoing multigene panel testing (MGPT) for cancer predisposition identified 36 individuals with pLoF variants in . Clinical features, tumor prevalence, and age at onset were compared with Lynch syndrome (LS) and wild-type (WT) cohorts.
Results: Thirty-six individuals (0.004%) had 28 unique pLoF variants in and a total of 42 primary tumors, 78.6% of which were CRC with a median age of diagnosis of 50 years. A total of 16.7% of individuals had multiple CRC primaries, and a majority (71.4%) were mismatch repair-proficient (pMMR). Signet ring cell (SRC) pathology was significantly enriched compared with WT ( = <.0001). The odds ratio for CRC was significantly higher than that for the -related LS cohort (odds ratio [OR], 45.3 [95% CI, 21.3 to 101] and OR, 16.9 [95% CI, 14.9 to 19.2], respectively).
Conclusion: is associated with early-onset, pMMR CRC enriched for SRC pathology. Comparison of prevalence showed a statistically significant two-fold increase in the odds of developing CRC compared with an LS cohort. These data confirm the gene-disease relationship between and CRC and support clinical management guidelines similar to -related LS.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406993 | PMC |
http://dx.doi.org/10.1200/PO-25-00214 | DOI Listing |
Mov Disord
August 2025
Department of Neuromuscular Diseases, University College London, Queen Square, Institute of Neurology, London, UK.
Background: ANK3 encodes ankyrin-G, a key scaffolding protein essential for neuronal function. While both monoallelic and biallelic ANK3 variants have been linked to neurodevelopmental disorders (NDDs), existing evidence for their pathogenicity and clinical correlation remains limited and heterogeneous.
Objective: To delineate the clinical features associated with biallelic ANK3 predicted loss-of-function (pLOF) variants.
JCO Precis Oncol
August 2025
Ambry Genetics Corporation, Aliso Viejo, CA.
Purpose: is a proposed colorectal cancer (CRC) predisposition gene, with only four families with putative loss-of-function (pLoF) variants published. The prevalence, phenotypic spectrum, and clinical management recommendations for heterozygotes remain unknown.
Methods: Retrospective review of approximately 950,000 individuals undergoing multigene panel testing (MGPT) for cancer predisposition identified 36 individuals with pLoF variants in .
Clin Cancer Res
August 2025
Rigshospitalet, Copenhagen, Capital Region of Denmark, Denmark.
Background: Cancer predisposition syndromes (CPSs) with pediatric onset are the leading known cause of childhood malignancies and are increasingly guiding clinical strategies in pediatric oncology. CPSs are placed under evolutionary negative selective pressure, but pediatric pancancer studies have so far failed to investigate genomic evolutionary metrics as a guide to predict penetrance and reveal novel CPSs.
Method: Germline whole-genome sequencing (WGS) in a 5-year prospective, registry-validated, nationwide cohort of individuals diagnosed with cancer before 18 years of age.
Stem Cell Res
September 2025
Hawaii Permanente Medical Group, Kaiser Permanente, Mapunapuna Medical Office, USA. Electronic address:
We have generated four human iPSC lines from skin biopsy-derived fibroblast cells with pathogenic variants in OPA1. Donors have a clinical diagnosis of optic atrophy. Three harbor heterozygous presumed loss-of-function (pLOF) variants, c.
View Article and Find Full Text PDFGenetics
September 2025
Department of Medical Genetics, University of British Columbia, Life Sciences Institute, The University of British Columbia, 2350 Health Sciences Mall, Vancouver, British Columbia, Canada V6T 1Z3.
The Polycomb Repressive Complex 2 is an epigenetic reader/writer that methylates histone H3K27. Rare germline partial loss-of-function (pLoF) variants in core members of the complex (EZH2, EED, and SUZ12) cause overgrowth and intellectual disability syndromes, whereas somatic variants are implicated in cancer. However, up to 1% of the general population will have a rare variant in one of these genes, most of which would be classified as variants of uncertain significance (VUS).
View Article and Find Full Text PDF